Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesFibroblasts in fibrosis: novel roles and mediatorsMesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal DialysisTargeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblastsImpaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis.Immune-Mediated Repair: A Matter of Plasticity.A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related FibrosisEndothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathwaysRole of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesRecent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.Strategy for treatment of fibrosis in systemic sclerosis: Present and future.Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?Current and future direction in the management of scleroderma.The molecular pathogenesis of morphoea: from genetics to future treatment targets.Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseasesPathogenesis of systemic sclerosis-current concept and emerging treatments.Pathophysiological Mechanisms in Sclerosing Skin Diseases.Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing.α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis.Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry.Test of Antifibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients.Human Fibrotic Diseases: Current Challenges in Fibrosis Research.Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.Right Ventricle Remodeling and Function in Scleroderma Patients.IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.Role of the mTOR pathway in minor salivary gland changes in Sjogren's syndrome and systemic sclerosis
P2860
Q26748338-91D78166-5482-42FA-B282-BD03725B495FQ26998508-DBE59FA1-5BAF-4581-80D8-AA73E69FB2B8Q28390104-9FC1B32F-D824-495A-8096-9EFFCD35CCF0Q33603627-6ABA2BD7-EA86-4E57-B196-7661505F4FCDQ33982509-9C5ED6A3-8919-4D0C-AEFE-26513AD36009Q34389943-08E5F50D-2E0E-45CF-9C87-3902228FA4C4Q34416229-8C80E4A3-FFD6-48FE-855C-4B1BFA130497Q34556402-2E65F934-564A-439D-848A-D27D22C830ECQ35587696-248386CA-CAE2-409B-8DCF-C332F4D39877Q35770782-007B5BF0-6705-4873-9AA0-FB39641E6AECQ36591533-D4A8BEC2-89B9-4628-B305-19398125E67EQ37224668-669E2D88-5B80-487E-9AD9-64EC13CB4DD3Q37381549-1305D3E5-516E-4F7C-9FD4-3BBB26479177Q38187607-CFF131B5-8F7C-43C5-88E0-27C3D93BD59DQ38701990-9D9EBA69-8D12-4D7B-B046-C3061EFF4FC7Q38710580-7E465996-EDCA-49E0-8E79-0613185684CEQ38823948-9BBA7883-180D-48A5-8049-B945FDF612DEQ38828584-2E6478CB-5E7C-488D-AD5E-73AFD796122AQ38936954-C69A1BC1-A492-4A31-BC82-274D62A25C56Q39211384-CE22726D-547A-4A98-989F-0DF489E45111Q39294794-CE0A2FB1-0916-4B39-B139-FBBCC08A28CCQ41462744-CFFA177E-4FFE-4E9E-A0DF-D6A4F8807DB3Q41630154-C1316D10-84E9-44A5-82E1-11562061FA46Q41811106-DDFE0C8A-C236-446B-8D68-92951716BD05Q42075625-F5CB574C-5B56-444F-9F80-6ED5BD4AAB5EQ47133681-401C58FE-5A36-43CD-B776-93915D2F5B77Q48096975-BC708299-03BD-4C00-9DD1-5E906FB5D696Q50079567-B2846A0A-2C87-4051-B6D8-A979D87924F7Q52536468-372D0673-8FD5-4F4E-89F1-C51D40F1BCAAQ52605977-7AD0C255-DDCB-4764-9040-3CB0ACE67935Q52973999-7879C7C4-8FF5-4103-A548-9662F2971820Q55153213-35AD6D62-D1E8-4C80-B714-818CBA737DC2Q55283549-BCC4F52E-1ACE-491A-9150-050EEE735758Q58800566-A74B4249-2F72-45DA-9DB0-14FDC5EC1FD8
P2860
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@ast
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@en
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@nl
type
label
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@ast
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@en
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@nl
prefLabel
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@ast
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@en
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@nl
P2093
P2860
P921
P3181
P356
P1476
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
@en
P2093
Adrian J Gilbane
Alan M Holmes
Christopher P Denton
P2860
P2888
P3181
P356
10.1186/AR4230
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1032324177